Edition:
United Kingdom

Mirati Therapeutics Inc (MRTX.OQ)

MRTX.OQ on NASDAQ Stock Exchange Global Select Market

41.14USD
15 Oct 2018
Change (% chg)

-- (--)
Prev Close
$41.14
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
166,632
52-wk High
$64.15
52-wk Low
$12.30

Chart for

About

Mirati Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of targeted oncology products. The Company's clinical pipeline consists of three product candidates: MGCD265, MGCD516 and mocetinostat. MGCD265 and MGCD516 are orally-bioavailable, spectrum-selective kinase... (more)

Overall

Beta: 1.68
Market Cap(Mil.): $362.06
Shares Outstanding(Mil.): 24.97
Dividend: --
Yield (%): --

Financials

  MRTX.OQ Industry Sector
P/E (TTM): -- 85.91 32.75
EPS (TTM): -3.43 -- --
ROI: -91.06 1.70 14.60
ROE: -91.23 3.17 16.33

BRIEF-Mirati Therapeutics Reports Q1 Loss Per Share $0.51

* MIRATI THERAPEUTICS REPORTS FIRST QUARTER FINANCIAL RESULTS

07 May 2018

Earnings vs. Estimates